
Reset all filters
01 3Livtencity
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 65
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 117
2022 Revenue in Millions : 65
Growth (%) : 104
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2024 Revenue in Millions : 202
2023 Revenue in Millions : 116
Growth (%) : 74